Marker Therapeutics Inc (MRKR)

[Stockdoggy]

I can see why some (ok, most) are disappointed with CC and recent events. I am too, but do not see the news as all that terrible. Hopefully, just a bit of a technical issue with the hold that will be resolved any day now, as the FDA clock started ticking on Halloween. My two positive takeaways regarding this are that the “agency had no concerns with the design of the AML trial” and that the “agency has noted the safety profile of the overall therapy”.

TPIV trial being stopped is also disappointing but understandable. The worst thing you can do is keep wasting money on something that does not have a future. TPIV trials were always icing on the cake, IMO. MultiTAA is the holy grail here.

As to why the hold was not announced sooner, I can only speculate. Perhaps, like me, they felt that this is a relatively minor issue that could possibly be resolved before the CC? We may never know.

I expect the share price the take a hit today. My hope is that it is accompanied by quite a bit of short covering. I am more concerned about the short number than the science or perceived management mistakes. Short squeezes are rare these days, and the sooner shorts cover, the better I will feel about things. Hang in there, longs...